登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C14H13N3O4S2
化学文摘社编号:
分子量:
351.40
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24
InChI
1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+
InChI key
DWMREKMVXIFPFM-ACCUITESSA-N
grade
pharmaceutical primary standard
API family
meloxicam
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
正在寻找类似产品? 访问 产品对比指南
Analysis Note
这些产品仅供测试和化验使用。它们不适用于人类或动物，也不能用于诊断、治疗或治愈任何类型的疾病。
Application
美洛昔康USP参标准品，预期用途是USP规定的指定质量测试和检测。也用于USP各论，例如：
- 美洛昔康口服混悬液
- 美洛昔康片
General description
本产品按照发行药典的发行和规定提供。支持本产品的所有信息，包括安全数据表和任何产品信息传单，都是在发行药典的授权下开发和发布的。如需进一步信息和支持，请访问现行药典网站。
Other Notes
可能适用相应的销售限制。
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
flash_point_f
Not applicable
flash_point_c
Not applicable
Roy Fleischmann et al.
Expert opinion on pharmacotherapy, 3(10), 1501-1512 (2002-10-22)
Meloxicam (Mobic trade mark, Boehringer Ingelheim) is a relatively new oral non-steroidal anti-inflammatory drug (NSAID) approved for the treatment of osteoarthritis in the US. It has also been evaluated for the treatment of rheumatoid arthritis, ankylosing spondylitis and acute 'rheumatic'
R Andrew Moore et al.
The Cochrane database of systematic reviews, (4)(4), CD007552-CD007552 (2009-10-13)
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) used mainly in treating pain associated with arthritis. The usual oral dose for osteoarthritis is 15 mg daily, but lower doses of 7.5 mg are advised in older patients. This review sought to
Keiko Ogino et al.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 120(6), 391-397 (2003-01-17)
Meloxicam (Mobic) is a new nonsteroidal anti-inflammatory drug (NSAID) derived from enolic acid, exhibiting selectivity for cyclooxygenase (COX)-2 over COX-1. Meloxicam has shown potent anti-inflammatory and analgesic activity together with low gastrointestinal toxicity in animal models. It is a potent
[Pharma-Clinics. The drug of the month. Meloxicam (Mobic)].
A J Scheen
Revue medicale de Liege, 52(4), 309-311 (1997-04-01)
[Efficacy and intolerance of meloxicam in injection and tablet form].
V P Tiurin et al.
Voenno-meditsinskii zhurnal, 324(11), 54-58 (2004-01-17)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持